Cellebrite DI Ltd. (CLBT)
Cellebrite DI Statistics
Share Statistics
Cellebrite DI has 239.47M shares outstanding. The number of shares has increased by 16.65% in one year.
| Shares Outstanding | 239.47M |
| Shares Change (YoY) | 16.65% |
| Shares Change (QoQ) | 15.08% |
| Owned by Institutions (%) | 52.47% |
| Shares Floating | 87.6M |
| Failed to Deliver (FTD) Shares | 302 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.06M, so 0.44% of the outstanding shares have been sold short.
| Short Interest | 1.06M |
| Short % of Shares Out | 0.44% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -16.31 and the forward PE ratio is 55. Cellebrite DI's PEG ratio is -0.08.
| PE Ratio | -16.31 |
| Forward PE | 55 |
| PS Ratio | 11.5 |
| Forward PS | 6.6 |
| PB Ratio | 13.73 |
| P/FCF Ratio | 39.02 |
| PEG Ratio | -0.08 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cellebrite DI.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.92 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.09 |
| Interest Coverage | 0.16 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $343.79K |
| Profits Per Employee | $-242.51K |
| Employee Count | 1,167 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 7 |
Taxes
| Income Tax | 7.02M |
| Effective Tax Rate | -2.54% |
Stock Price Statistics
The stock price has increased by 83.41% in the last 52 weeks. The beta is 1.44, so Cellebrite DI's price volatility has been higher than the market average.
| Beta | 1.44 |
| 52-Week Price Change | 83.41% |
| 50-Day Moving Average | 18.82 |
| 200-Day Moving Average | 18.72 |
| Relative Strength Index (RSI) | 56.25 |
| Average Volume (20 Days) | 1.67M |
Income Statement
In the last 12 months, Cellebrite DI had revenue of 401.2M and earned -283.01M in profits. Earnings per share was -1.35.
| Revenue | 401.2M |
| Gross Profit | 338.61M |
| Operating Income | 56.91M |
| Net Income | -283.01M |
| EBITDA | 67.51M |
| EBIT | 56.91M |
| Earnings Per Share (EPS) | -1.35 |
Balance Sheet
The company has 191.66M in cash and 10.97M in debt, giving a net cash position of 180.69M.
| Cash & Cash Equivalents | 191.66M |
| Total Debt | 10.97M |
| Net Cash | 180.69M |
| Retained Earnings | -164.86M |
| Total Assets | 690.57M |
| Working Capital | 272.09M |
Cash Flow
In the last 12 months, operating cash flow was 126.84M and capital expenditures -8.57M, giving a free cash flow of 118.27M.
| Operating Cash Flow | 126.84M |
| Capital Expenditures | -8.57M |
| Free Cash Flow | 118.27M |
| FCF Per Share | 0.56 |
Margins
Gross margin is 84.4%, with operating and profit margins of 14.18% and -70.54%.
| Gross Margin | 84.4% |
| Operating Margin | 14.18% |
| Pretax Margin | -68.79% |
| Profit Margin | -70.54% |
| EBITDA Margin | 16.83% |
| EBIT Margin | 14.18% |
| FCF Margin | 29.48% |
Dividends & Yields
CLBT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CLBT is $24, which is 20.6% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24 |
| Price Target Difference | 20.6% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 8.98 |
| Piotroski F-Score | 3 |